【Molecular composition】：

【CAS NO】：475207-59-1

【source】：Dasatinib

【authentication】：—

【specifications】：Anhydrate / Monohydrate

【DMF】：—

【use to】：

Dasatinib is indicated for the treatment of adults with chronic, accelerated, or myeloid or lymphoid blast phase chronic myeloid leukemia with resistance or intolerance to prior therapy including imatinib.